MITALAB OFFICIALLY BECOMES A COMPREHENSIVE DISTRIBUTION PARTNER OF ILLUMINA

Dear Valued Partners and Customers,

Mitalab is honored to announce a significant strategic milestone in our collaboration journey. Effective from May 13, 2026, Mitalab has officially become the comprehensive distributor of both Illumina’s “IVD Diagnostics” and “RUO Research” product portfolios. Illumina is globally recognized as a leading innovator in genomic sequencing and biotechnology. Becoming an authorized distributor for both the IVD and RUO product lines not only marks a major advancement in the partnership between Mitalab and Illumina, but also demonstrates Mitalab’s professional expertise, operational capability, and strong reputation in the healthcare and life sciences sector.

Mitalab is committed to delivering a comprehensive Next-Generation Sequencing (NGS) ecosystem that simultaneously supports clinical applications, enhances diagnostic and treatment efficiency, and advances in-depth scientific research. As modern medicine and genomic technologies continue to play an increasingly vital role in healthcare, Mitalab’s access to Illumina’s advanced platforms will create new opportunities to improve the quality of medical diagnosis, laboratory services, and scientific research for hospitals, laboratories, research institutes, and the scientific community across Vietnam.

This milestone is not only a source of pride for Mitalab, but also a strong motivation for us to continuously update and deliver cutting-edge medical technologies, contributing to the advancement of diagnostics, scientific innovation, and community healthcare. Once again, congratulations on this remarkable and meaningful partnership milestone.